Pepperstone: Pfizer’s earnings will be closely watched as the firm continues its turnaround efforts, with the stock having underperformed the S&P YTD, bulls will hope the report isn’t a tough pill to swallow

Make a post in our subreddit XGramatikInsights, and your thoughts will appear here!

Share the Post: